SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-A12B:
[]
CPHI [CHINA PHARMAS,] DEF 14C: (Original Filing)
[Payment of Filing Fee (Check the appropriate box): [X] No fee required. [ ] Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies: 2) Aggregate number of securities to which transaction applies: 3)]
GRO [AGRIA] 6-K: (Original Filing)
[Agria Corporation /s/ Guanglin Lai Name: Guanglin Lai Title: Chairman of the Board of Directors and Chief Executive Officer Description 99.1 Press release Notification of Late Filing Beijing, China June25, 2009 Agria has been unable to complete its 2008 20-F within the prescribed time because of delays in completing the preparation of its annual financial]
GRO [AGRIA] 6-K: Agria Corporation /s/ Guanglin Lai Name: Guanglin Lai
[Agria Corporation /s/ Guanglin Lai Name: Guanglin Lai Title: Chairman of the Board of Directors and Chief Executive Officer Description 99.1 Press release Notification of Late Filing Beijing, China June25, 2009 Agria has been unable to complete its 2008 20-F within the prescribed time because of delays in completing the preparation of its annual financial]
GRO [AGRIARP] NT 20-F: (Original Filing)
[PART II RULES 12b-25(b) AND (c) o (a) The reason described in reasonable detail in Part III of this formuld not be eliminated without unreasonable effort or expense (b) The subject annual report, semi-annual report, transition report on Form10-K, Form20-F, Form11-K, FormN-SAR or FormN-CSR, or portion thereof, will be filed on or before the fifteenthlendary]
GRO [AGRIARP] NT 20-F: PART II RULES 12b-25(b) AND (c) o (a)
[PART II RULES 12b-25(b) AND (c) o (a) The reason described in reasonable detail in Part III of this formuld not be eliminated without unreasonable effort or expense (b) The subject annual report, semi-annual report, transition report on Form10-K, Form20-F, Form11-K, FormN-SAR or FormN-CSR, or portion thereof, will be filed on or before the fifteenthlendary]
